Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tariffs
Pharma
AstraZeneca's Truqap falls short in another phase 3 trial
AstraZeneca has come up short in another phase 3 trial of Truqap, raising more questions about the blockbuster potential of the first-in-class drug.
Kevin Dunleavy
Apr 29, 2025 3:26pm
Novartis builds momentum with new drug launches
Apr 29, 2025 10:52am
Merck breaks ground on $1B Keytruda production site in Delaware
Apr 29, 2025 9:56am
Amgen blueprints $900M expansion at Ohio biomanufacturing plant
Apr 25, 2025 2:43pm
AbbVie plots $10B US outlay as pharma tariff threat looms
Apr 25, 2025 11:52am
Enhertu, Akeso, Fujifilm-Regeneron—Fierce Pharma Asia
Apr 25, 2025 8:45am
